Engineered cornea more resistant to chemical injury
(Medical Xpress) -- A new study from the University of Reading has established that a prosthetic cornea made from human cells is the best model for testing how irritants and toxins cause eye injuries.
The engineered cornea so closely resembles a natural cornea that it is a more reliable method of assessing damage caused by chemicals to the surface of the eye. One of these, sodium lauryl sulphate, is very common in shampoos, hair conditioners and toothpaste and was used in the study.
Existing models do not consider the important influence that mechanical properties, such as stiffness, play in directing normal cell growth. The leading model uses a material many times stiffer than the natural cornea, and another popular test uses one that is less stiff. The Reading model uses a surface that mimics the stiffness of a human cornea.
Corneal tissue engineering has improved dramatically over recent years as demand has grown. More than 48,000 cornea transplants have been recorded on the UK Transplant Registry since the Corneal Transplant Service began in 1983, and this is set to rise a with an ageing population. Currently corneal transplantation requires a continuous supply of health donor corneas.
An effective engineered replacement is essential if current levels of corneal transplantation are to be maintained.
The scientific advancements recently made at Reading in corneal biology and biomaterials can now, for the first time, be combined to create an accurate model of the cornea applicable to both toxicity testing and transplantation.
Dr Che Connon, from Reading School of Pharmacy, uses compressed collagen gels to engineer the prosthetic cornea which result in a much smoother and stiffer surface on which to grow cells than normal collagen. This technique represents the ultimate in biocompatibility as it results in a biomaterial comprised wholly of human proteins.
"Most irritants cause a temporary stinging, such as when shampoo gets into your eye," said Dr Connon. "However, we need to make sure that transplants using engineered material are as robust as possible - people who have already experienced loss of vision through damage to their own cornea need the confidence to know that their transplant is up to the job.
"This latest study proves that our prosthetic cornea was more resistant to chemical irritation. Compressed collagen cells which more accurately mimic the corneal surface provide the most protection against toxic assault."
Previously Dr Connon and Professor Ian Hamley in the Department of Chemistry engineered a tissue suitable for cornea transplantation using human stem cells. The research team developed a prosthetic cornea comprised solely from human cells and proteins, their growth and development having been directed by a synthetic polymer template which mimics the cornea's natural architecture
The paper, Influence of substrate on corneal epithelial cell viability within ocular surface models', by Yun Feng, James Foster, Shengli Mi, Bo Chen, and Che John Connon, is published in Experimental Eye Research.
The research has been funded by the Biotechnology and Biological Sciences Research Council.
Provided by University of Reading
- Seeing the world with new eyes: Biosynthetic corneas restore vision in humans Aug 25, 2010 | not rated yet | 0
- The role of stem cells in renewing the cornea Oct 02, 2008 | not rated yet | 0
- Two patients in Scotland get stem cell transplants to treat blindness May 22, 2012 | not rated yet | 0
- Vitamin B-based treatment for corneal disease may offer some patients a permanent solution Oct 24, 2011 | not rated yet | 0
- Stem cells can repair a damaged cornea Mar 05, 2012 | not rated yet | 0
- Motion perception revisited: High Phi effect challenges established motion perception assumptions Apr 23, 2013 | 3 / 5 (2) | 2
- Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update) Apr 02, 2013 | 4.5 / 5 (11) | 5
- The visual system as economist: Neural resource allocation in visual adaptation Mar 30, 2013 | 5 / 5 (2) | 9
- Separate lives: Neuronal and organismal lifespans decoupled Mar 27, 2013 | 4.9 / 5 (8) | 0
- Sizing things up: The evolutionary neurobiology of scale invariance Feb 28, 2013 | 4.8 / 5 (10) | 14
Question about perception of colors around light sources
3 hours ago When I look at a distant light source (like car headlights, or street lamp lights) I notice colors of the visible spectrum (as separated (as in after...
Does a charged particle rotate when traveling through a static Bf?
4 hours ago I have been looking at mass spectrometers, in particular the interactions between the Bf ind of a charged particle in motion in a static Bf of the...
Find a link between physics and assignment problems
5 hours ago Hi ! I've been working about assignments problems and how to solve them. I will have to do a presentation about it in few weeks. However, I'll...
Light as a source of electricity
6 hours ago Hello Dear Fellows! We all know that light is an electromagnetic wave and also we know that an antenna receives EM waves and...
A question about the energy stored in a capacitor.
6 hours ago If we imagine a simple circuit with a battery and a capacitor with negligible internal resistance, the capacitor is charged up to a point where the...
Electric field-Charge inside a metallic shell
8 hours ago I am having few doubts while studying electric field which i am putting here Suppose there is a spherical metallic shell with point charge q1 at...
- More from Physics Forums - Classical Physics
More news stories
The most common cause of failure after glaucoma surgery is scarring at the surgical site, so researchers are actively looking for ways to minimize or prevent scar formation. Previous work had suggested that vascular endothelial ...
Ophthalmology May 17, 2013 | not rated yet | 0 |
New research is emphasizing the importance of regular screenings for glaucoma, a disease that deteriorates the optic nerve over time and is a leading cause of irreversible blindness worldwide. The onset of glaucoma is associated ...
Ophthalmology May 17, 2013 | not rated yet | 0 |
The University of Nottingham and Nottingham University Hospitals NHS Trust, have been working with Sony Computer Entertainment Europe (SCEE) to develop special 3-D glasses and games to help treat children ...
Ophthalmology May 08, 2013 | not rated yet | 0
The first successful cornea transplant with donor endothelial tissue preloaded by an eye bank has been performed at Massachusetts Eye and Ear in Boston, Mass. Roberto Pineda II, M.D., Director of the Refractive Surgery Service ...
Ophthalmology May 07, 2013 | 5 / 5 (1) | 0
Adding omega-3 fatty acids did not improve a combination of nutritional supplements commonly recommended for treating age-related macular degeneration (AMD), a major cause of vision loss among older Americans, ...
Ophthalmology May 06, 2013 | 3 / 5 (2) | 0 |
Researchers at the University of Wisconsin have identified a potential new risk factor for obstructive sleep apnea: asthma. Using data from the National Institutes of Health (Heart, Lung, and Blood Institute)-funded Wisconsin ...
5 hours ago | not rated yet | 0 |
A new study looking at sleep-disordered breathing (SDB) and markers for Alzheimer's disease (AD) risk in cerebrospinal fluid (CSF) and neuroimaging adds to the growing body of research linking the two.
5 hours ago | 5 / 5 (1) | 0 |
In their quest to learn more about the variability of cells between and within tissues, biomedical scientists have devised tools capable of simultaneously measuring dozens of characteristics of individual ...
6 hours ago | 5 / 5 (1) | 0 |
Scientists at Johns Hopkins have turned their view of osteoarthritis (OA) inside out. Literally. Instead of seeing the painful degenerative disease as a problem primarily of the cartilage that cushions joints, ...
6 hours ago | 5 / 5 (2) | 0 |
Gourmands and foodies everywhere have long recognized ginger as a great way to add a little peppery zing to both sweet and savory dishes; now, a study from researchers at Columbia University shows purified components of the ...
5 hours ago | not rated yet | 0
The hunt for an HIV vaccine has gobbled up $8 billion in the past decade, and the failure of the most recent efficacy trial has delivered yet another setback to 26 years of efforts.
10 hours ago | not rated yet | 0